Biolongevity published an article breaking down Recombinant Follistatin (FLGR242) and the myostatin pathway.
Published
Signal category
Research & Knowledge
Quote
“In this deep dive, I break down Recombinant Follistatin (FLGR242) and why targeting the myostatin pathway has generated so much interest in the world of muscle, performance, and longevity.”
— Jay Campbell|Biolongevity team
Company
Biolongevity
Where Science Meets Longevity.
- Industry
- Wellness and Fitness Services
- Company size
- 4 employees
BioLongevity Labs is advancing the science of living better, longer. We develop science-driven solutions designed to support longevity, human performance, metabolic health, recovery, and overall vitality. At the intersection of emerging longevity science and real-world application, BioLongevity Labs is focused on translating advances in human biology into innovative products and protocols that help people optimize how they feel, function, and age. Our approach is rooted in a simple belief: longevity isn't just about adding years to life. It's about improving the quality of those years. Through a commitment to scientific rigor, thoughtful formulation, and continuous innovation, we're building a new generation of longevity solutions for people who want to take a more proactive role in their health. The Science of Living Better, Longer.
Founded 2026